ClinicalTrials.gg
RecruitingNCT07041905Updated Nov 16, 2026

Effects of Total and Selective Caries Removal - Requiring or Avoiding Vital Pulp Therapy - on Pulp Vitality and Postoperative Pain in Deep Carious Mature Permanent Teeth: A Split-Mouth Clinical Study

An interventional study of Total Caries Removal and Selective Caries Removal in Pulp Exposure, Dental and Deep Dental Caries, sponsored by Cukurova University. Recruiting at 1 site in Turkey (Türkiye). Open to participants aged 15 Years to 55 Years. Per ClinicalTrials.gov, last updated 2026-11-16.

Sponsored by Cukurova University · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Jul 2025; still recruiting 1 year 4 months later.
Updated Nov 16, 2026Study completion movedGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
15
Allocation
Randomized
Ages
15 Years to 55 Years
Sex
All
01

Study summary

The effect of selective caries cleaning and total caries cleaning on pulp health and post operative pain in teeth with deep caries will be investigated.

02

Conditions studied

  • Pulp Exposure, Dental
  • Deep Dental Caries

Browse trials for

03

In context

Dental Pulp Exposure

31 studies on the registry are indexed under Dental Pulp Exposure; 5 are open to participants now.

This study's planned enrollment of 15 is below the median of 53 across 29 interventional studies indexed under Dental Pulp Exposure.

Browse Dental Pulp Exposure studies →

Lead sponsor

Cukurova University is the lead sponsor of 261 studies on the registry; 48 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
15 Years to 55 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients aged ≥15 years with bilateral deep carious mature permanent teeth.
  • Positive vitality test (cold sensitivity).
  • No spontaneous pain or periapical radiolucency.
  • Willingness to attend 6- and 12-month follow-ups

Exclusion criteria

Exclusion Criteria:

  • Uncontrolled systemic diseases Pregnancy or allergy to dental materials used Teeth with irreversible pulpitis (spontaneous pain, necrosis) Non-restorable teeth (fractures, extensive decay)
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
15 participants (estimated)

Study arms

  • Active comparator
    Arm 1

    Complete caries excavation

    Procedure: Total Caries Removal

  • Experimental
    Arm 2

    Partial caries excavation

    Procedure: Selective Caries Removal

Interventions

  • ProcedureTotal Caries Removal

    Arm 1: "Total caries removal (complete excavation to hard dentin)"

  • ProcedureSelective Caries Removal

    Partial removal leaving affected dentin near pulp.

06

What researchers measure

Primary outcomes

  1. Early postoperative pain intensity (VAS) after total vs. selective excavation

    The patient will be asked to rate his/her pain on day 1, 3 and 7 according to VAS

    Time frame: first week

  2. dentin bridge formation

    no dentin bridge formation is expected in selective caries cleaning, while dentin bridge formation will be observed radiologically in total cleaning

    Time frame: twelve months

  3. pulp survival at twelve months

    The pulp is expected to remain vital, with no percussion tenderness and no spontaneous pain

    Time frame: twelve months

07

Study locations

1 of 1 sites recruiting
08

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jul 2025 to primary completion in Feb 2026, 7 months.

Of 13 interventional studies with no phase under Dental Pulp Exposure, half reached primary completion within 14 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 15. This study's 7 months is below that.

Completion moved once since we started tracking on Sep 25, 2026: Aug 2026 → Mar 2027, on Nov 16, 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Jun 19, 2025
First posted
Jun 27, 2025
StartActual
Jul 1, 2025
Primary completionActual
Feb 1, 2026
CompletionEst.
Mar 1, 2027was Aug 2026
Last update
Nov 16, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Study completion
Aug 1, 2026→Mar 1, 2027
Nov 16, 2026
Show all 1 update
  1. Nov 16, 2026
    Study completion Aug 1, 2026→Mar 1, 2027
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT07041905
Responsible party
Zehra SUSGUN YILDIRIM (Principal Investigator, Cukurova University) — Principal investigator
First posted
Jun 27, 2025
Start date
Jul 1, 2025
Primary completion
Feb 1, 2026
Completion
Mar 1, 2027 (estimated)
Last update
Nov 16, 2026

Study contacts

Zehra Zehra Susgun Yıldırım, Principal investigator
Contact
susgunzehra@gmail.com
0553 454 1123

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion